Timothy R. Hance

Associate

+1 858 550 6145
trhance@cooley.com

Timothy R. Hance has a general corporate practice representing technology and life science companies at every stage of the company life cycle, from entity formation, to debt and equity financings, to mergers and acquisitions, to public offerings and SEC reporting and compliance.

Download full bio

Experience

  • Phathom Pharmaceuticals - $209 Million IPO 

  • Exagen Diagnostics – $58 Million IPO  

  • Novo Holdings Leads $72 Million Series E for LanzaTech 

  • ShockWave Medical – $111 Million IPO 

  • Gossamer Bio – $317 Million IPO 

  • View all

Education

  • Harvard Law School
    JD, 2017

  • University of California, Davis
    BA, History
    2009


Admissions & Credentials

California

Media & Insight

Contact

+1 858 550 6145 office
trhance@cooley.com

4401 Eastgate Mall
San Diego, CA 92121-1909